Wellington Management Group’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
Other funds holding MLYS
Wellington Management Group's MLYS Position: Q3 2026 in Review
Wellington Management Group reduced its Mineralys Therapeutics (MLYS) stake by 70% in Q3 2026, selling an estimated $15.3M and leaving 243,759 shares worth $6.13M. The position accounts for ﹤0.01% of the portfolio, ranked #1397.
Wellington Management Group first reported a position in MLYS in Q1 2023 and has held it in 10 quarters since. The position peaked at $91M in Q1 2026. 219 funds tracked by Wall St. Rank hold MLYS as of Q3 2026.
- Wellington Management Group held 243,759 shares of Mineralys Therapeutics worth $6.13M as of Q3 2026.
- Wellington Management Group sold 562,957 Mineralys Therapeutics shares in Q3 2026, an estimated $15.3M.
- Mineralys Therapeutics made up ﹤0.01% of Wellington Management Group's portfolio in Q3 2026, its #1397 holding.
- Wellington Management Group first reported a position in Mineralys Therapeutics in Q1 2023 and has held it in 10 quarters since.
- Wellington Management Group's Mineralys Therapeutics position peaked at $91M in Q1 2026.
- 219 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q3 2026.
Based on Wellington Management Group's 13F filing for Q3 2026, filed 16 Nov 2026.